CHIERON ACTIVE INGREDIENTS PRIVATE LTD
CHIERON ACTIVE INGREDIENTS PRIVATE LTD (India) holds 16 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 14 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “CHIERON ACTIVE INGREDIENTS PRIVATE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/chieron-active-ingredients-private-ltd
Overview
CHIERON ACTIVE INGREDIENTS PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 22 active FDA Type II Drug Master Files, covering 1-CHLORO-6,6-DIMETHYLHEPT-2-EN-4-YNE; DAPAGLIFLOZIN PROPANEDIOL; ESCITALOPRAM OXALATE USP; FLUCONAZOLE USP; IRBESARTAN USP; LACOSAMIDE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which CHIERON ACTIVE INGREDIENTS PRIVATE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
CHIERON ACTIVE INGREDIENTS PRIVATE LTD holds 16 active (16 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- OSELTAMIVIR PHOSPHATEActive2026-04-14
- DAPAGLIFLOZIN PROPANEDIOLActive2025-11-27
- RITALINIC ACIDActive2025-10-23
- RIVAROXABAN USPActive2025-07-01
- SITAGLIPTIN PHOSPHATE MONOHYDRATE USPActive2025-06-12
- WARFARIN SODIUM CLATHRATEActive2021-10-14
- TETRACAINE HYDROCHLORIDEActive2021-06-22
- VILDAGLIPTINActive2021-05-21
- RISPERIDONEActive2021-03-26
- LINAGLIPTINActive2021-03-20
- LEVETIRACETAMActive2020-10-27
- OLMESARTAN MEDOXOMIL-ROUTE AActive2019-10-08
- LACOSAMIDEActive2019-02-04
- TETRACAINE USPActive2010-08-26
- OLMESARTAN MEDOXOMILActive2009-09-30
- WARFARIN SODIUM USP (AMORPHOUS)Active2008-08-25
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to CHIERON ACTIVE INGREDIENTS PRIVATE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to CHIERON ACTIVE INGREDIENTS PRIVATE LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this CHIERON ACTIVE INGREDIENTS PRIVATE LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.